首页> 外文OA文献 >Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

【2h】

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

机译：醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌的早期PSA下降和PSA进展时间相关；日本2期试验的事后分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Masahiko Nakayama; Hisanori Kobayashi; Tomihiro Takahara; Ryo Oyama; Keiichiro Imanaka; Kazutake Yoshizawa;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials [J] . Masahiko Nakayama, Hisanori Kobayashi, Tomihiro Takahara, BMC Urology . 2016,第1期

机译：在醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌中，早期PSA下降与PSA进展时间相关。日本2期试验的事后分析
2. Independent association between time to prostate-specific antigen (PSA) nadir and PSA progression-free survival in patients with docetaxel-naive, metastatic castration-resistant prostate cancer receiving abiraterone acetate, but not enzalutamide [J] . Miyake Hideaki, Hara Takuto, Tamura Keita, Urologic oncology . 2017,第6期

机译：在多西紫杉醇 - 幼稚园，转移性阉割的前列腺癌患者接受醋酸盐的患者的患者的患者中，抗原抗原（PSA）Nadir和PSA无进展生存之间的独立关联。
3. Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration-resistant prostate cancer [J] . Fenioux Charlotte, Louvet Christophe, Charton Emilie, BJU international . 2019,第2期

机译：从转移性阉割的前列腺癌患者的无症状PSA进展中从Abiraaterone加上泼尼松加上Abiraatorone加上地塞米松
4. Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials [O] . Masahiko Nakayama, Hisanori Kobayashi, Tomihiro Takahara, 2016

机译：醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌的早期PSA下降和PSA进展时间相关；日本2期试验的事后分析
5. Treatment of Metastatic Castration-resistant Prostate Cancer With Abiraterone and Enzalutamide Despite PSA Progression [O] . DANIEL J. BECKER, ARJUN D. IYENGAR, SALMAN R. PUNEKAR, 2019

机译：尽管PSA进展，但仍用ABIRATERONE和烯醇酰胺治疗转移性阉割前列腺癌

Association of early PSA decline and time to PSA progression in abiraterone acetate-treated metastatic castration-resistant prostate cancer; a post-hoc analysis of Japanese phase 2 trials

著录项

引文网络

相似文献

相关主题

期刊订阅